[Various immunological and immunomorphological changes in patients with breast cancer after interferon administration].
The immunologic and immunomorphologic effect of native alpha-interferon eta phi-II Parenteral) in 12 patients with stage II breast cancer was studied. A preoperative course of interferon injected into tumor was found to induce local and general immunomodulating effect which suggested activation of cellular antitumor immunity.
D001943:Breast Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007370:Interferon Type I / Q000627:therapeutic use*; D007957:Leukocyte Adherence Inhibition Test; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology
D007370:Interferon Type I
O nekotorykh immunologicheskikh i immunomorfologicheskikh sdvigakh u bol'nykh rakom molochnoĭ zhelezy pri vvedenii interferona.